Scientific Committees
Scientific Committee on Food
Outcome of discussions
Minutes of the
123
rd Plenary Meeting of the Scientific Committee
on Food held on 16 - 19 October 2000 in Brussels
ATTENDANCE LIST LISTE DES PARTICIPANTS
TEILNEHMERLISTE
Members/Membres/Mitglieder
Mrs. S. BARLOW, Mr. A. CARERE, I.
ELMADFA (2
nd Vice-chairman, Vice President, Stellv.
Vorsitzender), Mrs. A. FERRO-LUZZI, Mr. A. FLYNN (17/10 and
thereafter), R. FRIES (18/10), W. GRUNOW, Mrs. A. KNAAP (1
st Vice-chairman, Vice President, Stellv.
Vorsitzender), Mr. I. KNUDSEN (Chairman, President,
Vorsitzender), S. LINDGREN (present on 17/10 and 18/10), B.
MOSELEY (present on 17/10 pm and thereafter), K.-H. NAU
(present on 16/10 and 17/10), A. PALOU (present on 18/10 pm
and thereafter), W. SARIS (present on 17/10 and 18/10), P.
TOBBACK (present on 17/10 pm and thereafter), P. VERGER
(present on 17/10 pm and thereafter), J.-M. WAL (present on
18/10 pm and thereafter), R. WALKER (present on 17/10 pm
and thereafter)
Experts:
J. ALEXANDER (present on 17/10 and
thereafter, items 7 & 8), A. DI DOMENICO (present on
17-18/10, item 7 ), J.C. LARSEN (present on 17-18/10, item
7), A. RENWICK (present on 18 and 19/10, item 8), G.
SPEIJERS (present on 17/10, item 7), H. VAN DEN BERG
(present on 19/10, item 8)
Apologies for absence:
D. BOSKOU
Commission/Kommission
Mr. R. BATES (DG Fishery), Mr. L. ROSSI
(DG Health and Consumer Protection), Mrs. C. SANDVIK (DG
Health and Consumer Protection), Mr. F. VERSTRAETE (DG
Health and Consumer Protection)
Secretariat/Secrétariat/Sekretariat
(DG Health and Consumer Protection)
Mr. M.A. GRANERO ROSELL, D. PETTAUER, D.
LIEM, M. ROMARÍS, Mrs. H. PEDERSEN
1. Apologies for absence
Apologies were received from D.
Boskou.
2.
Adoption of the agenda
The draft agenda was adopted.
3. Declarations of interest
There were no interests declared.
4.
Adoption of the minutes of the 122
nd meeting
The draft minutes of the 122
nd plenary meeting held on 6 and 7 September
2000 were discussed and accepted after the introduction of
a few corrections.
5.
Matters arising since last Plenary
Mr. Granero introduced the new members
of the Secretariat. Dr. D. Liem joined the team recently.
He is a seconded national expert from the Netherlands. He
has collaborated with the Committee in the past. Dr.
Romarís, a biologist, also joined recently the team on a
temporary basis. They both are already helping supporting
several working groups of the Committee. Lastly, Mme Hanne
Pedersen replaced Mme Enza Agro.
6.
General information from the Commission
services
The Commission services, at the occasion
of the possibly last meeting of the present mandate wished
to thank the members of the Committee for their hard work
during the last three years of mandate. On behalf of the
Commission services, Mr. Peter Wagstaffe, Head of the Unit
C/3 "Management of Scientific Committees II; scientific
co-operation and networks", responsible for the management
of several Scientific Committees including the SCF
addressed the Committee highlighting some facts regarding
its the activity during the present term.
The SCF has held during these three
years 15 plenary sessions and nearly 100 meetings of
Working Groups of the SCF. This represents about 360
meeting days. More than 70 additional experts have
contributed with their expertise to supplement that of the
members of the Committee. Besides the already very
important amount of time spent discussing in meetings,
there is also a very substantial amount of time devoted to
the preparation and study of dossiers that are then
reported and discussed in the meetings themselves. During
this period the Committee has celebrated its 25 years
anniversary of existence since the Scientific Committee for
Food was created in 1974.
Mr. Wagstaffe made a balance of the
Committee's output in the last three years. The Committee
has issued more than 70 opinions relating to more than 200
substances or compounds in food during this last three
years. These opinions cover many different areas where the
Commission has sought the advice of the Committee mainly
with the purpose of creating or adapting legislative
measures. In many of these cases, the measures are included
in the programme of the White Paper on Food Safety. In a
number of cases, the request for advice by the Commission
has come with urgency and the Committee has in all cases
responded in an efficient and timely manner. To name a few
of these
urgent requests, he mentioned the question of the
levels of acceptable pesticide residues in baby food, the
so called "negative list" for GM products, and the question
of the dioxin contamination incident in Belgium, and the
recent request about the invocation of the safeguard clause
under the Novel Food Regulation by the Italian
government.
The opinions adopted by the Committee in
this period comprise full evaluations of a number of
important
contaminants such as dioxins (being discussed at
this meeting) and a number of mycotoxins: ochratoxin A,
zerealenone, deoxynivalenol, fumonisin and nivalenol. The
Commission has used or is using this advice to incorporate
it in the appropriate legislation.
The Committee has also examined some
aspects of the
microbiological risks in the food supply, in
particular the case of
Listeria monocytogenes, Vibrio cholera in certain
foodstuffs,
Aeromonas in natural mineral waters or potential
microbiological contamination of soups and
consommés.
In the new area of
novel foods, the Committee has evaluated a
genetically modified tomato, has issued advice on the
products derived from genetically modified organisms but
where no presence of DNA or protein can be detected, and
has examined the scientific arguments by the Italian
authorities regarding the suspension of the marketing of a
number of products. The Committee has also evaluated a
number of novel foods not related to genetic manipulation:
phytosterol esters in fat spreads, a new egg yolk, nangai
nuts,
Stevia rebaudiana leaves.
In the field of
dietetic foods and nutrition, the Committee has
provided the scientific basis for the directives on
pesticide residues in baby foods, the directive for
specific foods for sportspeople and the directive on
nutrient sources that may be used in the different dietetic
foods. The Committee has been working very thoroughly
during this period in the area of establishing upper levels
for vitamins and minerals. This area is becoming very
important in view of the ongoing debate about food
supplements and food fortification. As in many other areas
these are also measures foreseen in the White Paper. The
Committee also addressed the question of the unexpected
results of the chemopreventive studies with beta carotene
and has carried out a detailed review of the safety of beta
carotene. The Committee also looked into the safety aspects
of the addition of high amounts of caffeine, taurine, and
glucuronolactone to certain socalled energy drinks.
The Committee has evaluated or
re-evaluated the safety of a number of
food additives in this period. Among them, there are
five sweeteners and also other additives. The Committee has
also examined a substantial number of dossiers relating to
new or alternative manufacturing processes of existing
authorised additives, for which companies have asked the
Commission to modify the existing specifications. Again the
Commission has used the advice when preparing updates or
modifications of the relevant legislation.
The Committee has also provided advice
to the Commission on the area of
flavourings. It has advised the Commission on
setting up the programme for evaluation of chemically
identified flavouring substances registered in the
Community. It has also re-evaluated the safety of
coumarin.
The Committee has continued with its
evaluation of the
food contact materials, the majority of which are
plastic materials. More than 150 substances have been
evaluated or re-evaluated during this period by the
Committee.
The applicability of the ADI approach
when evaluating chemicals such as food additives that could
be consumed by babies and infants had also been discussed
by the SCF.
Besides working in the SCF, members of
the Committee have also actively contributed to the other
sister Scientific Committees where this has been necessary.
This has happened at the level of plenary meetings and
working groups of the Scientific Steering Committee, the
Scientific Committee on Plants, the Scientific Committee on
Veterinary measures relating to Public Health, the
Scientific Committee on Animal Nutrition and the Scientific
Committee on Toxicity and Ecotoxicity and the
Environment.
The SCF has also contributed to the
debate about the future Food Authority issuing some
comments.
Far from having finished its tasks, the
Committee has still a heavy workload in front. The future
looks promising and it is clear that the expertise of the
Committee and its members will continue to serve the public
interest in the area of food safety, likely in better and
more efficient manners.
Mr. Wagstaffe ended by thanking the
members of the SCF not only for the mass of work
accomplished as mentioned before but also for the permanent
spirit of constructive collaboration with the Commission
services.
Both the Commission services and the
Committee wished to thank the experts who have supplemented
the expertise of the Committee in this period for specific
issues for their kind and precious collaboration. The list
of additional experts appears as appendix I to these
minutes.
7. Contaminants
7.1. Risk assessment of dioxins and dioxin-like PCBs
in food. Draft opinion
The comprehensive draft report was
introduced by the chair of the Task Force on Dioxins.
During the thorough discussions the Committee identified a
number of issues that required detailed further
consideration. The Committee could therefore not agree on a
final text and decided that the remaining issues should be
addressed by a smaller group consisting of SCF members and
experts. The revised report would then be considered at the
next plenary meeting. According to the provisional schedule
this meeting would be held under the new mandate of the
SCF.
The Committee noted that the Commission
will propose measures on dioxins and PCBs in food on the
basis of the scientific opinion of the SCF.
7.2. Fusarium toxins - fumonisin B1. Draft opinion
The rapporteur introduced the draft
opinion prepared by the Working Group on Contaminants.
There was general satisfaction among the members about the
contents of the opinion. During the discussion a few
editorial remarks were made and it was agreed to include
more information with respect to the dietary exposure of
the general population. The Committee recalled that a SCOOP
exercise has recently been started to collate and compile
data on the occurrence of fumonisin B1 in
foodstuffs.
The draft opinion on fumonisin B1 was
adopted after the introduction of amendments proposed
during the discussion. The full text of this opinion
appears as Annex I to these minutes.
7.3. Fusarium toxins - nivalenol. Draft opinion
The rapporteur introduced the draft
opinion prepared by the Working Group on Contaminants. The
report was adopted after introduction of minor editorial
changes.
The Committee noted that a group
assessment of fusarium toxins will be carried out after
completion of the evaluation of the individual toxins. The
full text of this opinion appears as Annex II to these
minutes.
8.
Upper levels for vitamins and minerals
8.1. - Draft guidelines for the development of upper
levels of intake for vitamins and minerals
The rapporteur introduced the draft
guidelines as prepared by the Task Force already discussed
at an earlier plenary session.. During the discussion a
number of clarifications were introduced in the text. Once
the issues were resolved and subject to the incorporation
of them in the text, the guidelines were adopted. They
appear as Annex III.1 to these minutes.
The Committee also discussed how to
express clearly the ongoing work for the remaining of the
29 vitamins and minerals not yet evaluated this time and
how this task will be completed in the future.
8.2. - Draft opinion on the upper level for beta
carotene
An earlier draft had already been
discussed at the previous plenary. After discussion the
draft was adopted with some further minor changes. The full
opinion appears as Annex III.2 to these minutes
8.3. - Draft opinion on the upper level for vitamin B
2
The draft was presented and discussed.
During the discussion, a number of studies that might have
an impact on the derivation on an upper level were
identified that needed detailed consideration. The
Committee decided to send the draft back for further
consideration of these elements.
8.4. - Draft opinion on the upper level for folate
The consideration of the upper level for
folate had been already discussed at an earlier plenary
meeting. During the discussion some mostly editorial
changes were identified. The text was considered agreed.
The full opinion appears as Annex III.3 to these
minutes.
8.5. - Draft opinion on the upper level for vitamin B
6
The draft was introduced by the
rapporteur and discussed. The final text was adopted after
the inclusion of a few modifications. The full text appears
as Annex III.4 to these minutes.
8.6. - Draft opinion on the upper level for vitamin B
12
The draft presented by the rapporteur
was introduced. It was discussed and a certain number of
changes were agreed to make clear the opinion of the
Committee on the upper level for this vitamin. The full
text appears as Annex III.5 to these minutes.
8.7. - Draft opinion on the upper level for
selenium
The rapporteur presented the changes in
the draft opinion introduced after the discussion in the
last plenary. A few amendments were proposed in the
sections on critical effects derivation of the upper level,
and the risk characterisation. The opinion was adopted
after the introduction of the changes proposed. It appears
as Annex III.6 to these minutes.
8.8. - Draft opinion on the upper level for
manganese
The rapporteur presented the changes in
the draft opinion introduced after the discussions at the
last plenary. A number of further amendments were
considered. The final text was agreed. It appears as Annex
III.7.
8.9. - Draft opinion on the upper level for
molybdenum
The Committee had held a discussion on
the upper level for molybdenum at an earlier meeting and
decided to come back to it when a number of other
micronutrients were also discussed. A number of changes to
the draft were discussed to make it more clear.
The final opinion appears as Annex III.8
to these minutes.
9. Novel Foods
9.1. - Draft opinion on bacterial dextrans
A previous draft had been presented at
the last SCF plenary meeting and had been referred back for
further consideration of some details. The new draft was
presented by the rapporteur and was adopted, pending
inclusion of minor mostly editorial remarks that were
discussed and agreed. The full text of this opinion appears
as Annex IV to these minutes.
10.
Food contact materials
10.1. - Update of the SCF guidelines for the
evaluation of food contact materials of 1990: Draft
"Presentation of an application for assessment of a
substance to be used in food contact materials prior to
its authorisation"
Due to lack of sufficient time, this
item could not be discussed and therefore was
postponed.
10.2. - Draft opinion on the 11
th list of monomers and additives for food
contact materials
The Chairman of the Working Group
introduced the draft opinion prepared by the Group. subject
to a number of editorial changes the text was adopted. The
full text appears as Annex V to these minutes.
10.3. - Opinion on a survey on intakes of
di-2-(ethylhexyl) adipate (DEHA)
The draft prepared by the Working Group
was introduced and discussed. Subject to a number of
presentational changes to clarify the issue the final text
was adopted. The full text appears as Annex VI to these
minutes.
11. Additives
11.1. - Updating of the existing guidelines (1992):
Draft guidance on submissions for food additive
evaluations by the SCF
Due to lack of time, this item had to be
postponed.
11.2 - Statement on benzoates and parabens
The Committee evaluated benzoic acid and
benzoates (E210-213) (Opinion on benzoic acid and its
salts) in its opinion of 25 February 1994 (35
th series of reports of the SCF, 1996). The
Committee established at the time a temporary ADI of 0-5
mg/kg bw, as the sum of benzoic acid and its salts,
expressed as benzoic acid. The Committee commented that a
study to investigate clastogenic activity
in vivo was needed and a study to investigate
teratogenicity was desirable. Information on consumer
intakes of benzoic acid and its salts was also
needed.
The Committee evaluated also at the same
time the parabens, (E214-220), (Opinion on
p-hydroxybenzoic acid alkyl esters and their sodium
salts, 25 February 1994, 35
th series of reports of the SCF, 1996). It
established a temporary ADI of 0-10 mg/kg bw, as the sum of
methyl, ethyl and propyl
p-hydroxybenzoic acid and their sodium salts. The
Committee commented that a cell proliferation study in the
rat forestomach and a rat teratology study were needed.
Information on consumer intakes of parabens was also
needed.
The Committee expressed in both opinions
the wish to review the situation within 3 years. The
Committee wishes to indicate that it has not yet received
any submission regarding these two groups of additives but
still wishes to review their safety, taking account of any
new toxicological data including the studies requested in
the 1994 opinions. In view of the time that has now
elapsed, the Committee will consider withdrawing the
temporary ADIs for these substances if the requested
information is not provided within the next 12
months.
In the meantime, the Committee wishes to
emphasise that the existing safety information on these
substances gives sufficient reassurance that current uses
are temporarily acceptable and that these additives perform
an important preservative function in foods. Furthermore
the Committee notes that benzoic acid is found naturally,
albeit at relatively low levels, in foods such as fruits,
and that benzoate is a normal product of intermediary
metabolism.
12.
Statement on coumarin
Further to its opinion of 1999 on
coumarin (expressed on 22 /9/99), the Committee has
received information about recently completed toxicity,
metabolic and mechanistic studies and has been informed
about progress in relevant ongoing research. These studies
are regarded as particularly pertinent to the issues raised
by the Committee in its 1999 opinion with respect to the
mode of action of coumarin and interspecies differences in
toxicity. The Committee was informed that the ongoing
studies should be completed within 12 months and would wish
to review the study reports when available. In the
meantime, the Committee reiterates the request in its 1999
opinion for a study of in vivo DNA-binding and DNA-adduct
formation in rats in the relevant target organs, in order
to help to clarify the mode of action. The Committee also
reiterates its recommendation that current extent and
levels of use should not increase.
13.
Any other business
No other business was discussed.
14.
Adoption of these minutes
These minutes were adopted at the 124
th plenary meeting of the SCF on 21 November
2000.
ANNEXES
(The text of the opinions adopted in
these annexes appear in the section outcome/opinions of the
webpages of the SCF on the Internet, not in the section
outcome/minutes).
ANNEX I
Opinion of the SCF on fumonisin B1
(SCF/CS/CNTM/MYC/24Final)
ANNEX II
Opinion of the SCF on nivalenol (SCF/CS/CNTM/MYC/26
Final)
ANNEX III
Annex III.1
SCF Guidelines for the development of Tolerable Upper
Intake Level for vitamins and minerals
(SCF/CS/NUT/UPPLEV/11 Final)
Annex III.2
Opinion of the SCF on the Tolerable Upper Intake Level
of beta carotene SCF/CS/NUT/UPPLEV/37 Final
Annex III.3
Opinion of the SCF on the Tolerable Upper Intake Level
of folate SCF/CS/NUT/UPPLEV/18 Final
Annex III.4
Opinion of the SCF on the Tolerable Upper Intake Level
of vitamin B
6
SCF/CS/NUT/UPPLEV/16 Final
Annex III.5
Opinion of the SCF on the Tolerable Upper Intake Level
of vitamin B
12
SCF/CS/NUT/UPPLEV/42 Final
Annex III.6
Opinion of the SCF on the Tolerable Upper Intake Level
of selenium (SCF/CS/NUT/UPPLEV/25 Final)
Annex III.7
Opinion of the SCF on the Tolerable Upper Intake Level
of manganese (SCF/CS/NUT/UPPLEV/21 Final)
Annex III.8
Opinion of the SCF on the Tolerable Upper Intake Level
of molybdenum (SCF/CS/NUT/UPPLEV/22 Final)
ANNEX IV
Opinion of the SCF on bacterial dextrans
(SCF/CS/NF/DOS/7 Final)
ANNEX V
Opinion of the SCF on the 11
th list of monomers and additives for food
contact materials (SCF/CS/PM/GEN/M83 Final)
ANNEX VI
Opinion of the SCF on a survey on dietary intake of the
food contact material di-2-(ethylhexyl) adipate (DEHA)
(SCF/CS/PM/3276 Final /31920)
APPENDIX
List of additional experts who have
supplemented the expertise of the Committee for specific
issues in the period November 1997- November 2000.
Prof. Dr. J. ALEXANDER
|
National Institute of Public
Health, Oslo, Norway
|
Dr. V. AZAIS-BRAESCO
|
Institut National de la Recherche
Agricole (INRA) CRNH UMMM, Centre de
Clermont-Ferrand/Theix, France
|
Dr. A. BERG
|
Med. Universitätklinik,
Universität Freiburg, Freiburg, Germany
|
Dr. C. BÖHME
|
Bundesinstitut für
gesundheitlichen Verbraucherschutz und
Veterinärmedizin (BgVV), Berlin, Germany
|
Dr. J. CARSTENSEN
|
Copenhagen, Denmark
|
Dr. J-J. CASTEGNARO
|
International Agency for Research
on Cancer (IARC), Lyon, France
|
Dr. L. CASTLE
|
Ministry of Agriculture Fisheries
& Food, Central Science Laboratory, York, United
Kingdom
|
Dr. P. COOK
|
Department of Health, London,
United Kingdom
|
Dr. R. CREBELLI
|
Istituto Superiore di Sanitá, ISS,
Roma, Italy
|
Prof. D. DAVIES
|
Imperial College of Science,
Technology and Medicine, The Hammersmith Hospital,
London, United Kingdom
|
Dr. A. DI DOMENICO
|
Istituto Superiore di Sanitá,
Roma, Italy
|
Dr. G. DIRHEIMER
|
Institut de Biologie Moléculaire
et Cellulaire du CNRS, Strasbourg, France
|
Dr. B. DUSEMUND
|
BgVV, Berlin, Germany
|
Prof. Dr. P. ELIAS
|
Karlsruhe, Germany
|
Dr. A. FEIGENBAUM
|
DS NHSA-INRA, Paris, France
|
Dr. P. FÜRST
|
Chemisches Landes und Staatliches
Veterinäruntersuchungsamt, Münster, Germany
|
Prof. Dr. R. GILBERT
|
London, United Kingdom
|
Dr. J. GREIG
|
Department of Health, London,
United Kingdom
|
Dr. K. GROB
|
Kantonales Labor, Zürich,
Switzerland
|
Dr. J. GRY
|
Veterinær- og Fødevaredirektoratet
(VFD), Søborg, Denmark
|
Dr. D. GÜRTLER
|
BgVV, Berlin, Germany
|
Dr. T. HALLAS-MØLLER
|
VFD, Søborg, Denmark
|
Prof. Dr. W. HAMMES
|
Institut für
Lebensmitteltechnologie, Stuttgart, Germany
|
Dr. J. HERITAGE
|
University of Leeds, Leeds, United
Kingdom
|
Dr. N-G. ILBÄCK
|
Levsmedelsverket (NFA), Uppsala,
Sweden
|
Dr. JACQUIN NAVARRO
|
Laboratorio de Coexphal, Almería,
Spain
|
Prof. S. KARENLAMPI
|
University of Kuopio, Kuopio,
Finland
|
Dr. O. LADEFOGED
|
VFD, Søborg, Denmark
|
Dr. C. LAGRUE
|
Centre STIFL de St-Rémy, St.-Rémy,
France
|
Dr. J.C. LARSEN
|
VFD, Søborg, Denmark
|
Prof. J.-C. LHUGUENOT
|
ENSBANA, Dijon, France
|
Dr. A.K.D. LIEM
|
Rijksinstituut voor
Volksgezondheid en Milieu (RIVM), Bilthoven, The
Netherlands
|
Prof. R. MAUGHAN
|
University Medical School,
Aberdeen, United Kingdom
|
Dr. A. MANTOVANI
|
ISS, Roma, Italy
|
Dr. M. MEIJERINK
|
RIVM, Bilthoven, The
Netherlands
|
Dr. W. MENNES
|
RIVM, Bilthoven, The
Netherlands
|
Dr. O. MEYER
|
VFD, Søborg, Denmark
|
Dr. R. MITCHELL
|
PHLS Environmental Communicable
Disease Surveillance Centre, London, United
Kingdom
|
Dr. A. MORTENSEN
|
VFD, Søborg, Denmark
|
Dr. C. MULHOLLAND
|
Department of Health, London,
United Kingdom
|
Dr. J.-F. NARBONNE
|
Laboratoire de
Physico-Toxicochimie des Systèmes Naturels,
Université de Bordeaux, Bordeaux, France
|
Dr. C. NGUYEN-THE
|
INRA-Station de technologie des
produits végétaux, Avignon, France
|
Dr. S. NOTERMANS
|
TNO Nutrition and Food Research,
Zeist, The Netherlands
|
Prof. D. PARENT-MASSIN
|
ESMISAB, Plouzane, France
|
Dr. P.-L. PENTTILA
|
National Food Administration of
Finland, Helsinki, Finland
|
Dr. E. RASMUSSEN
|
VFD, Søborg , Denmark
|
Prof. A. RENWICK
|
University of Southampton,
Southampton, United Kingdom
|
Dr. R. RIJK
|
TNO Nutrition and Food Research,
Zeist, The Netherlands
|
Prof. E. RODRIGUEZ-CEREZO
|
Centro Nacional de Biotecnología,
Madrid, Spain
|
Dr. D. SCANDELLA
|
CTIFL, Runigs, France
|
Prof. C. SCHLATTER
|
Zürich, Switzerland
|
Prof. J. SCHLATTER
|
Bundesamt für Gesundheitswesen,
Switzerland
|
Dr. E. SCHMIDT
|
BgVV, Berlin, Germany
|
Dr. K. SCHUMANN
|
Walther Strauss Institut, Institut
für Pharmakologie und Toxikologie, Munich,
Germany
|
Dr. J. SHAVILA
|
Department of Health, London,
United Kingdom
|
Prof. N. SKOVGAARD
|
Birkerod, Denmark
|
Dr. G. SPEIJERS
|
RIVM, Bilthoven, The
Netherlands
|
Dr. A STAMMATI
|
ISS, Roma, Italy
|
Dr. J. STEADMAN
|
London, United Kingdom
|
Dr. I. THORUP
|
VFD, Søborg, Denmark
|
Dr. J.G.M. VAN ENGELEN
|
RIVM, Bilthoven, The
Netherlands
|
Dr. H. VAN DEN BERG
|
TNO Nutrition and Food Research,
Zeist, The Netherlands
|
Dr. F. VAN LEUSDEN
|
RIVM, Bilthoven, The
Netherlands
|
Dr. F.X.R. VAN LEEUWEN
|
WHO European Centre for
Environment and Health (ECEH), Bilthoven, The
Netherlands
|
Dr H. VAN LOVEREN
|
RIVM, Bilthoven, The
Netherlands
|
Dr. P. VOYSEY
|
Chipping Campden Food Research
Association, Chipping Campden, United Kingdom
|
Prof. Dr J. G. VOS
|
RIVM, Bilthoven, The
Netherlands
|
Dr. A. WAGENMAKERS
|
Universiteit van Maastricht,
Maastricht, The Netherlands
|
Prof. C. WILLIAMS
|
Loughborough University,
Loughborough, United Kingdom
|
Prof. R. ZITO
|
Istituto Regina Elena, Rome
|
Dr. F. ZUCCO
|
Istituto di Tecnologie Biomediche,
CNR, Roma, Italy
|
Scientific Committees
Scientific Committee on Food
Outcome of discussions
FOOD SAFETY |
PUBLIC HEALTH
|
CONSUMER
PROTECTION |
DIRECTORATE
GENERAL "HEALTH & CONSUMER PROTECTION"
|